Login / Signup

Reverse circadian glucocorticoid treatment in prepubertal children with congenital adrenal hyperplasia.

Ilja DubinskiSusanne Bechtold Dalla-PozzaMartin BidlingmaierNicole ReischHeinrich Schmidt
Published in: Journal of pediatric endocrinology & metabolism : JPEM (2021)
Our data do not support the use of RCT schemes for GC replacement in children with CAH due to lack of benefits and unknown long-term risks.
Keyphrases
  • young adults
  • electronic health record
  • big data
  • human health
  • risk assessment
  • climate change
  • replacement therapy
  • smoking cessation